This is a StreetInsider.com Premium Only Page

Incyte (INCY) – Major News

Feb 13, 2024 07:13 AM Incyte (INCY) Misses Q4 EPS by 8c

Feb 5, 2024 04:46 PM Incyte (INCY) Acquires Rights to Tafasitamab from MorphoSys (MOR)

Oct 31, 2023 07:00 AM Incyte (INCY) Misses Q3 EPS by 12c; misses on revenue

Aug 1, 2023 07:04 AM Incyte (INCY) Tops Q2 EPS by 28c, raises FY23 Guidance

May 2, 2023 09:12 AM Incyte (INCY) Misses Q1 EPS by 18c

Feb 7, 2023 07:04 AM Incyte (INCY) Tops Q4 EPS by 32c

Nov 1, 2022 07:06 AM Incyte (INCY) Tops Q3 EPS by 3c

Aug 2, 2022 07:08 AM Incyte (INCY) Tops Q2 EPS by 45c

May 3, 2022 07:11 AM Incyte (INCY) Misses Q1 EPS by 14c

Feb 8, 2022 07:05 AM Incyte (INCY) Misses Q4 EPS by 76c

Nov 2, 2021 07:16 AM Incyte (INCY) Tops Q3 EPS by 46c

Aug 3, 2021 07:22 AM Incyte (INCY) Tops Q2 EPS by 5c

May 4, 2021 07:18 AM Incyte (INCY) Tops Q1 EPS by 4c

Feb 9, 2021 07:14 AM Incyte (INCY) Tops Q4 EPS by 18c, Revenues Beat

Nov 5, 2020 07:38 AM Incyte (INCY) Misses Q3 EPS by 52c

Aug 4, 2020 07:16 AM Incyte (INCY) Tops Q2 EPS by 36c

Jun 29, 2020 07:07 AM Incyte (INCY) Tabrecta Approved in Japan for NSCLC

May 5, 2020 07:23 AM Incyte (INCY) Reports Q1 Loss of $2.86, Reaffirms Guidance

Feb 13, 2020 07:07 AM Incyte (INCY) Tops Q4 EPS by 8c, Revenues Beat

Oct 29, 2019 07:12 AM Incyte (INCY) Tops Q3 EPS by 17c, Revenues Beat; Raises FY19 Jakafi Revenue Outlook

Jul 30, 2019 07:06 AM Incyte (INCY) Tops Q2 EPS by 27c, Raises Guidance

Apr 30, 2019 07:12 AM Incyte (INCY) Tops Q1 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus

Feb 14, 2019 07:04 AM Incyte (INCY) Misses Q4 EPS by 7c

Oct 30, 2018 07:08 AM Incyte (INCY) Misses Q3 EPS by 2c, Revenues Miss; Lifts FY18 Revenue Mid-Point, Remains Below Consensus

Jul 31, 2018 07:13 AM Incyte (INCY) Q2 Revenue Tops Views

May 1, 2018 07:08 AM Incyte (INCY) Misses Q1 EPS by 2c

Apr 24, 2018 06:01 AM Eli Lilly & Co. (LLY) & Incyte Corporation (INCY) Confirms FDA Advisory Committee Recommends Approval of Baricitinib 2mg and Against 4mg

Apr 6, 2018 07:32 AM Incyte (INCY) Phase 3 ECHO-301 Study Didn't Meet Primary Endpoint

Feb 15, 2018 07:05 AM Incyte (INCY) Q4 Revenues Beat

Oct 31, 2017 07:09 AM UPDATE: Incyte (INCY) Tops Q3 EPS by 12c, Beats on Revenues; Boosts FY17 Jakafi Net Product Revenue Guidance

Aug 1, 2017 07:11 AM Incyte (INCY) Misses Q2 EPS by 3c, Sales Beat; Raises FY17 Jakafi Revenue Outlook

May 4, 2017 07:15 AM Incyte (INCY) Tops Q1 EPS by 4c

Apr 14, 2017 10:05 AM Eli Lilly (LLY), Incyte (INCY) Announce FDA CRL for RA Treatment Baricitinib

Mar 10, 2017 03:18 PM Gilead (GILD) Said Close to Pulling Trigger on Incyte (INCY) Takeover - Source

Feb 14, 2017 07:11 AM Incyte (INCY) Misses Q4 EPS by 8c

Nov 1, 2016 07:03 AM Incyte (INCY) Tops Q3 EPS by 21c; Raises Jakafi Revenue Outlook

Aug 9, 2016 07:02 AM Incyte (INCY) Tops Q2 EPS Views; Updates FY16 Outlook

May 9, 2016 07:15 AM Incyte (INCY) Reports Q1 EPS of 12c, Updates FY Guidance

Feb 11, 2016 08:34 AM Incyte (INCY) Tops Q4 EPS by 20c

Feb 11, 2016 06:46 AM Incyte (INCY) to Halt Ruxolitinib + Capecitabine Phase 3 in Advanced or Metastatic Pancreatic Cancer

Nov 3, 2015 07:06 AM Incyte (INCY) Misses Q3 EPS by 14c; Boosts FY15 Jakafi Net Revenue Outlook

Aug 4, 2015 07:16 AM Incyte (INCY) Tops Q2 EPS by 6c; Raises Jakafi Sales Guidance

Apr 30, 2015 10:03 AM Incyte (INCY) Misses Q1 EPS by 1c

Feb 12, 2015 07:30 AM Incyte (INCY) Misses Q4 EPS by 13c

Oct 30, 2014 07:21 AM Incyte (INCY) Tops Q3 EPS by 33c; Jakafi Sales Up 63%

Jul 31, 2014 07:13 AM Incyte (INCY) Misses Q2 on Top and Bottom

Feb 12, 2014 07:06 AM Incyte (INCY) Posts Q4 Loss of 15c/Share; Issues Outlook

Oct 31, 2013 09:22 AM Incyte (INCY) Misses Q3 EPS by 1c, Sales Beat

Aug 1, 2013 07:53 AM Incyte (INCY) Misses Q2 EPS by 3c

May 2, 2013 09:29 AM Incyte (INCY) Posts Q1 Loss of 12c/Share